Almontasheri Ali, Munshi Adeeb, Alotaibi Shomokh F, Munshi Areej, Alghamdi Ali, Hakami Salman A
Adult Allergy and Clinical Immunology, King Abdulaziz Medical City, Jeddah, SAU.
Internal Medicine, King Abdulaziz Medical City, Jeddah, SAU.
Cureus. 2024 Oct 30;16(10):e72683. doi: 10.7759/cureus.72683. eCollection 2024 Oct.
Introduction Anaphylactic shock is a severe and acute life-threatening condition triggered by exposure to common allergens. Despite the increasing incidence of anaphylaxis worldwide, there is still a lack of awareness and understanding of anaphylaxis and its proper management. Methods A descriptive survey design was used to evaluate the knowledge and awareness of anaphylactic shock among the general population in the western region of Saudi Arabia through an online questionnaire distributed from January 2024 to June 2024. The validated questionnaire included demographic information and 18 knowledge-based questions on anaphylaxis. Results The data was collected from 501 participants in the western region of Saudi Arabia. Among them, 290 (58%) were female, and 211 (42%) were male. The largest age group was between 41 and 50 years, comprising 121 participants (24.1%). Additionally, most participants, 298 (59.4%), held a bachelor's degree. A total of 207 participants (41.3%) reported either experiencing anaphylaxis or knowing someone who had. Furthermore, 123 participants (24.5%) underwent tests for anaphylaxis or anaphylactic shock, with 88 (17.5%) having a blood test and 35 (7%) having a skin prick test. In terms of knowledge about anaphylaxis, 266 participants (53%) were able to accurately identify multiple symptoms, while 195 (38.9%) were uncertain about the proper diagnostic methods. Moreover, only 92 (18.4%) recognized epinephrine as the first-line treatment, and 125 (25%) knew the correct administration route (intramuscular). 216 participants (43.1%) were aware of the need to visit the ER after using epinephrine. Furthermore, the survey findings indicated that 318 participants (63.5%) acknowledged the dangerous nature of anaphylaxis, with 258 (51.5%) believing that it could be fatal. However, 228 (45.5%) remained unsure about the risk of anaphylaxis-associated organ failure. Conclusion The study highlighted the need for targeted public awareness campaigns to improve understanding and ensure early recognition and correct management of anaphylaxis.
引言 过敏性休克是一种由接触常见过敏原引发的严重急性危及生命的病症。尽管全球范围内过敏反应的发病率不断上升,但对过敏反应及其正确管理仍缺乏认识和了解。方法 采用描述性调查设计,通过2024年1月至2024年6月分发的在线问卷,评估沙特阿拉伯西部地区普通人群对过敏性休克的知识和认识。经过验证的问卷包括人口统计学信息和18个关于过敏反应的基于知识的问题。结果 数据收集自沙特阿拉伯西部地区的501名参与者。其中,290名(58%)为女性,211名(42%)为男性。最大年龄组为41至50岁,有121名参与者(24.1%)。此外,大多数参与者298名(59.4%)拥有学士学位。共有207名参与者(41.3%)报告自己经历过过敏反应或认识有过过敏反应的人。此外,123名参与者(24.5%)接受过过敏反应或过敏性休克检测,其中88名(17.5%)进行过血液检测,35名(7%)进行过皮肤点刺试验。在关于过敏反应的知识方面,266名参与者(53%)能够准确识别多种症状,而195名(38.9%)对正确的诊断方法不确定。此外,只有92名(18.4%)认识到肾上腺素是一线治疗药物,125名(25%)知道正确的给药途径(肌肉注射)。216名参与者(43.1%)意识到使用肾上腺素后需要前往急诊室。此外,调查结果表明,318名参与者(63.5%)认识到过敏反应的危险性,258名(51.5%)认为过敏反应可能致命。然而,228名(45.5%)对过敏反应相关器官衰竭的风险仍不确定。结论 该研究强调需要开展有针对性的公众宣传活动,以提高认识并确保对过敏反应的早期识别和正确管理。